Search

everythinglearnresearchcommunity

for

Search:↓

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Sarcoidosis can cause scarring hair loss on the scalp, which is rare.

Hair loss in young adults is common and varies in pattern, cause, and type.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Using one's own fat may help treat hair loss.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Dermoscopy is useful for diagnosing lichen planopilaris and certain features may relate to disease duration, age, and gender.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Some people experienced hair loss after mesotherapy treatments for hair loss.

People with non-scarring hair loss have higher levels of DKK-1, a protein linked to hair growth, than those with scarring hair loss or no hair loss.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Dermoscopy helps distinguish between scarring and non-scarring hair loss and accurately diagnoses hair and scalp conditions without needing hair plucking.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Most hair disorder patients at the clinic were young adult males, with alopecia areata being the most common condition.